Difference between revisions of "Haloperidol (Haldol)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 2: | Line 2: | ||
First-generation typical antipsychotic with antiemetic properties. No known antineoplastic properties. | First-generation typical antipsychotic with antiemetic properties. No known antineoplastic properties. | ||
− | [[Category: | + | ==Also known as== |
+ | *'''Brand names:''' Haldol, Heloper, Serenace, Trancodol | ||
+ | [[Category:Drugs]] | ||
+ | [[Category:Intravenous medications]] | ||
+ | [[Category:Oral medications]] | ||
[[Category:Emesis prevention]] | [[Category:Emesis prevention]] | ||
[[Category:Antipsychotic]] | [[Category:Antipsychotic]] | ||
− | [[Category: | + | [[Category:FDA approved in 1967]] |
[[Category:WHO Essential Pain and Palliative Care Medicine]] | [[Category:WHO Essential Pain and Palliative Care Medicine]] |
Latest revision as of 19:19, 30 July 2018
Mechanism of action
First-generation typical antipsychotic with antiemetic properties. No known antineoplastic properties.
Also known as
- Brand names: Haldol, Heloper, Serenace, Trancodol